Celebrex (Celecoxib) Treatment of Laryngeal Papilloma

NCT00592319 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

10

Enrollment

OTHER

Sponsor class

Stopped 03/01/2009,due to date close to termination of this funding/study period

Conditions

Laryngeal Papilloma

Interventions

DRUG: Celebrex
DEVICE: PDL
PROCEDURE: CO2 laser or microsurgery

Sponsor

Boston University

Collaborators

[object Object]